Ottavio Arancio, M.D., Ph.D.

Affiliations: 
Pathology and Cell Biology Columbia University, New York, NY 
Google:
"Ottavio Arancio"
Mean distance: 12.69 (cluster 6)
 
SNBCP

Parents

Sign in to add mentor
Eric R. Kandel research scientist Columbia

Children

Sign in to add trainee
Ian J. Orozco grad student 2011 Columbia
Linda H. Lee grad student 2013 Columbia
Valentina Echeverria Moran research scientist 2005-2006 Columbia
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fiorito J, Vendome J, Saeed F, et al. (2017) Identification of a Novel 1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine Analog as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's Disease. Journal of Medicinal Chemistry
Koppensteiner P, Trinchese F, Fà M, et al. (2016) Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer's disease. Scientific Reports. 6: 32553
Teich AF, Sakurai M, Patel M, et al. (2016) PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease. Journal of Alzheimer's Disease : Jad
Nicholls RE, Sontag JM, Zhang H, et al. (2016) PP2A methylation controls sensitivity and resistance to β-amyloid-induced cognitive and electrophysiological impairments. Proceedings of the National Academy of Sciences of the United States of America
Fá M, Puzzo D, Piacentini R, et al. (2016) Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory. Scientific Reports. 6: 19393
Fà M, Zhang H, Staniszewski A, et al. (2015) Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Luo J, Lee SH, VandeVrede L, et al. (2015) Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia. Bmc Neuroscience. 16: 67
Lee L, Dale E, Staniszewski A, et al. (2015) Corrigendum: Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease. Scientific Reports. 5: 11782
Matsuzaki S, Lee L, Knock E, et al. (2015) SUMO1 Affects Synaptic Function, Spine Density and Memory. Scientific Reports. 5: 10730
Puzzo D, Gulisano W, Palmeri A, et al. (2015) Rodent models for Alzheimer's disease drug discovery. Expert Opinion On Drug Discovery. 10: 703-11
See more...